In this article we describe the expansion of in vitro osteogenic capability of human osteoblasts (HOS cells) after sorting by fluorescence-activated cell sorting (FACS) with the osteoblastic marker of human bone alkaline phosphatase (AP) monoclonal antibody. After culturing for 7 days, the HOS cells were incubated with fluorescein isothiocyanate (FITC)-labeled AP monoclonal antibody. The antibody recognized the cells with high AP activity (high AP cells), which were about 76% of the total cells. After the HOS cells were sorted, the high AP cells could be recovered, and almost all of them reacted strongly with the AP antibody. Therefore, we were able to condense the high AP cells about 1.3 times. We further cultured the sorted cells as well as the unsorted control cells. After the initial seeding, the culturing periods for both groups of cells were 20 days. At the end of this period, we measured AP activity per DNA and osteocalcin contents. In contrast to the low condensation ratio of the high AP cells in the sorted fraction, the AP activity and osteocalcin contents were about nine times and four times greater than those of the unsorted cells, respectively. These results demonstrated that using the sorting technique to isolate the high AP cells might be a useful method for applications in bone tissue engineering.
INTRODUCTION
cause of the limited supply of cells and efficiency of differentiation. Recently, it has been reported that recog-Effective technologies for the utilization of cultured nition of a cell surface enzyme of alkaline phosphatase cells have been developed for fabricating cell-based tis-(AP) is useful in the fractionation of the cell population sue-engineered devices. As a means of advancing the into AP-positive and AP-negative cells (12, 14) . tissue engineering approach, living cells with differenti-In this article we examined the use of a human bone ated functions could be incorporated into different types AP monoclonal antibody to distinguish cells with high of scaffold materials. We have previously reported that osteogenic capability from a human osteoblast-like cell mesenchymal stem cells (MSCs) derived from bone marline (HOS cells) (13). We then enriched the living osrow cells differentiate into osteoblasts, which form bone teogenic cells with high AP potential by cell sorting matrix on ceramic surfaces (7) (8) (9) (10) . MSCs are known to methods. include progenitor cells of multiple cell types (3, 4) . The presence of these multiple populations suggests a need MATERIALS AND METHODS for appropriate methods for the isolation and enrichment Cell Cultures of active osteogenic cells from other MSC lineages in order to show effective and immediate bone-forming ca-Human osteosarcoma cells, HOS cells (ATCC No. CRL-1543, Dainippon Pharmaceutical), were maintained pability. Fluorescence-activated cell sorting (FACS) with monoclonal antibodies is one principal technique for the with minimum essential medium (MEM) (Nacalai Tesque) containing 10% fetal bovine serum (FBS) (Hyclone), isolation and enrichment of needed cells, and monoclonal antibodies that recognize cells of the osteoblastic 10 mM β-glycerophosphate (Calbiochem), 0.28 mM ascorbic acid 2-phosphate (Wako Pure Chemical), 1% phenotype are required for their isolation. The effective methods for enrichment of cultured osteoblasts have po-nonessential amino acid (Invitrogen), and antibiotics (100 units penicillin, 0.1 mg streptomycin, 0.25 µg am-tentially important implications for clinical cases be-378 KOTOBUKI ET AL. photericin B ml, Sigma) under a 5% CO 2 atmosphere at Relative AP Activity Measurement 37°C. To enable the assay of flow cytometric (FCM) AP activity was determined as described by Reddi analysis, 2 × 10 5 cells were seeded in 60-mm Falcon tisand Sullivan, with minor modifications (11) . The HOS sue culture dishes with 5 ml each of the medium. The cells cultured for 4, 7, 11, 14, or 20 days and sorted APculture medium was replaced three times a week.
positive HOS cells cultured for 13 days were washed twice with PBS and scraped off into 1 ml of 10 mM Immunocytostaining
Tris-HCl buffer (pH 7.4, 1 mM EDTA, 100 mM NaCl). Mouse anti-human bone AP monoclonal antibodies,
The cell suspension was homogenized and sonicated, clone name B4-78, were isolated from hybridomas deafter which 20 µl of the sonicated cell suspension was veloped by the Developmental Studies Hybridoma Bank used for DNA quantification. The quantification of the (DSHB; Iowa, USA) according to previously reported DNA content was determined using Hoechst 33258. To methods (3, 6) . The antibody was purified with a protein measure the AP activity, another sonicated cell suspen-A conjugated sepharose column (Amersham Pharmacia sion was centrifuged at 10,000 rpm for 1 min at 4°C. Biotech) and then diluted to 1 mg/ml with phosphate-An aliquot (20 µl) of the supernatant was assayed for buffered saline (PBS). HOS cells at culture days 4, 7, AP activity using p-nitrophenyl phosphate substrate 11, 14, and 20 were used for immunocytostaining with-(Zymed). out fixation. The cells were preincubated with 10% casein in MEM for 30 min at 37°C to block nonspecific Quantification of Osteocalcin Deposited binding, and then incubated with a 1:100 dilution of B4on Cell Layers of HOS Cells by ELISA 78 at 37°C for 30 min. After exposure to a 1:100 dilution of FITC-conjugated goat anti-mouse IgG (Leinco) HOS cells cultured for 20 days or sorted AP-positive at 37°C for 20 min, the cells were observed under a HOS cells subcultured for 13 days were washed twice fluorescence microscope (Model IX70, Olympus) in fluwith PBS. Cell layers of the culture were collected by orescence mode at 200× magnification. Nonimmune scraping with 10 mM Tris-HCl buffer (pH 7.4, 1 mM mouse IgG (ICN) was used as a control in place of hu-EDTA, 100 mM NaCl). The collected samples were sonman bone AP antibodies.
icated and then centrifuged at 15,000 rpm for 10 min. The resulting pellets were collected and dissolved with Flow Cytometric Analysis and FACS 20% formic acid solution. After treatment of the samples for AP-Expressing HOS Cells in the formic acid, the samples were centrifuged at 3000 HOS cells were reacted with the human bone AP anrpm for 10 min and the supernatants were subjected to tibody, B4-78, and were then harvested with 0.25% trypgel filtration to eliminate inorganic ions. The gel-filtered sin/0.01% EDTA (Invitrogen). The harvested cells were samples were evaporated for concentration. The concenpassed through cell strainers (Becton-Dickinson) to retrated samples were added to the EIA plate immobilized move any cell clumps and resuspended in PBS at a final with anti-human osteocalcin antibody to measure the cell density of 5 × 10 5 cells/ml. FCM analysis of APconcentration of osteocalcin with an intact human osteoexpressing HOS cells was performed on a FACS Vancalcin EIA kit (No. BT-460, Biomedical Technologies tage SE system (Becton-Dickinson) equipped with an Inc.). A standard solution of human osteocalcin was seargon laser operated at 488 nm for green fluorescent quentially diluted with PBS(−) in the concentration emission. Fluorescence was detected with a 525 nm range of 0-50 ng/ml. bandpass filter. Unstained HOS cells were used to set the background level of fluorescence. The AP-express-RESULTS AND DISCUSSION ing cells were analyzed for fluorescence intensity and compared with the HOS cells incubated with control HOS cells show osteoblast-like phenotypes such as alkaline phosphatase (AP) expression and AP activity in IgG in place of human bone AP antibodies. After the FCM analyses, the cells were sorted with a FACS Van-vitro (11) . Relative AP activity per DNA content of HOS cells increased up to culture day 7 and exhibited tage SE system into high AP-positive cells or low APpositive cells. The sorted cells were collected in tubes the highest level at culture day 7 ( Fig. 1 ). After culture day 7, relative AP activity per DNA content decreased with MEM containing 20% FBS. After the cell sorting, the viability of the sorted cells was assessed by the try-in a time-dependent manner ( Fig. 1 ). Because the cells exhibited the highest AP activity at culture day 7 ( Fig.  pan blue exclusion test. The sorted cells were seeded in 24-well Falcon tissue culture dishes with 2 ml of the 1), it was easy to isolate the high AP-positive HOS cells from the cultured cells. Human bone AP antibody, clone medium at a cell density of 1 × 10 5 cells/ml and subcultivated.
name B4-78, was isolated and purified from conditioned distribution of cell size (forward scatter: FSC) and a relatively homogeneous cell granularity (side scatter: SSC) ( Fig. 3a) . A gated area (R1) was set up to remove small cell debris or large cell clumps (Fig. 3a) . On the level of fluorescence intensity, the HOS cells incubated with nonimmune mouse IgG instead of the AP primary antibody were used for compensation of fluorescence intensity to eliminate the background autofluorescence (Fig.  3c ). For the cells stained with the AP antibody, the intensity of fluorescein signals was maintained even after being treated with trypsin (data not shown). FCM analysis showed that the population of high AP-positive HOS cells seen in region 2 (R2) of Figure 3b was 76.2% of the total cells. In contrast, low AP-positive HOS cells seen in region 3 (R3) was 21.3%. After the HOS cells microscope. Phase contrast microscopy showed that the sorted cells seemed to be living due to high cell membrane integrity (Fig. 4a, c) . Actually, the viability of the media of cultured hybridomas. At culture day 7, we immunostained the HOS cells using the FITC-labeled AP sorted cells was greater than 95%, as determined by trypan blue exclusion test. Fluorescence microscopy re-antibodies without fixation, and then observed the cells under a fluorescence microscope. Fluorescence micros-vealed that all of the fractionated high AP-positive cells clearly had high green fluorescein signals around the copy demonstrated the cells with high fluorescent signals and low fluorescent signals (Fig. 2) . The immuno-cell membranes (Fig. 4b) . In contrast, the cells with low AP-positive cells showed very little fluorescent activity stained HOS cells at culture day 7 were harvested from the culture dishes and subjected to flow cytometric (Fig. 4d) . The results suggest that this FACS technique using an AP antibody (B4-78) could be a useful system (FCM) analysis. The analysis revealed a slightly broad for separating living osteoblasts with high osteogenic dant AP in the cell membrane of osteoblasts and osteocalcin is known to be a useful marker for bone-forming functions.
To check whether the sorted AP-positive HOS cells ability in osteoblasts (2, 15) . HOS cells at culture day 7 were subjected to cell sorting, fractionated into high AP-had retained their functions, we measured the AP activity as well as the osteocalcin expression of the sorted positive fraction, harvested, and then subcultured for 13 days. As the total culture period was 20 days, unsorted cells after a period of long-term culture because abun- cells at culture day 20 were treated as experimental control samples. Phase-contrast microscopy demonstrated that the sorted AP-positive HOS cells deposited abundant mineral substances around the cells to form bone matrix nodules compared with the unsorted control cells (Fig. 5) . Immunocytochemistry using the AP antibody revealed that the cells at subculture day 13 (total culture period of 20 days) expressed a high level of AP compared with the control cells at culture day 20 (Fig. 6) . To quantify the osteogenic activity of the sorted HOS cells with high AP activity, a biochemical assay was performed. Relative AP activity per DNA content was assayed and the osteocalcin incorporated into cell layers was measured with ELISA using anti-human osteocalcin antibody. Unsorted HOS cells contained about 76% high AP-positive cells, which appeared in the sorted fraction activity. In this regard, there have been some reports that specific cellular functions could be upregulated through osteoblastic activity using our sorting system. This stratcell-to-cell communications among different cell types egy could conceivably yield viable cells with high funcand extracellular matrices (1, 5) . Based on these results, tions to generate tissue-engineered devices for a wide we speculate that cell-to-cell interactions between the range of applications. sorted HOS cells with high AP activity can cause an
We have already adapted cellular therapy for skeletal upregulation of osteogenic ability. Thus, we might be reconstruction using MSCs derived from the bone marable to manipulate cellular functions to produce elevated row cells of patients. The therapy consists of two steps. The first step is to expand the number of MSCs. The second step is osteogenic differentiation of the MSCs followed by bone matrix formation on scaffolds such as ceramics. By achieving osteogenic differentiation, we could fabricate the cultured osteoblast/bone matrix construct (regenerative cultured bone) to express extensive osteogenic activity after in vivo implantation (16). Actually, we have previously reported that in vitro regenerative cultured bone tissue could exhibit an immediate new bone-forming capability after in vivo implantation. Our previous reports indicate the importance of osteogenic cells for skeletal reconstruction. Together with the present results, the high AP-positive cells obtained by FACS appear to be promising in offering suitable cell sources for creating osteogenic tissues. The method described in this article has clinical significance in the application of cultured bone tissues to a 
